| 001 | 168957 | ||
| 005 | 20240229133632.0 | ||
| 024 | 7 | _ | |a 10.1038/s41375-021-01298-y |2 doi |
| 024 | 7 | _ | |a pmid:34031532 |2 pmid |
| 024 | 7 | _ | |a 0887-6924 |2 ISSN |
| 024 | 7 | _ | |a 1476-5551 |2 ISSN |
| 024 | 7 | _ | |a altmetric:106374300 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2021-01159 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Salwender, Hans |0 0000-0001-7803-0814 |b 0 |
| 245 | _ | _ | |a Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial. |
| 260 | _ | _ | |a London |c 2021 |b Springer Nature |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1634305689_1828 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2021 Oct;35(10):3007-3011 |
| 536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de |
| 700 | 1 | _ | |a Elmaagacli, Ahmet |b 1 |
| 700 | 1 | _ | |a Merz, Maximilian |b 2 |
| 700 | 1 | _ | |a Miah, Kaya |0 P:(DE-He78)b97fc5666ea8f9db9ef499de6b2397cf |b 3 |u dkfz |
| 700 | 1 | _ | |a Benner, Axel |0 P:(DE-He78)e15dfa1260625c69d6690a197392a994 |b 4 |u dkfz |
| 700 | 1 | _ | |a Haenel, Mathias |b 5 |
| 700 | 1 | _ | |a Jehn, Christian |b 6 |
| 700 | 1 | _ | |a Mai, Elias K |0 0000-0002-6226-1252 |b 7 |
| 700 | 1 | _ | |a Bertsch, Uta |b 8 |
| 700 | 1 | _ | |a Blau, Igor W |b 9 |
| 700 | 1 | _ | |a Scheid, Christof |b 10 |
| 700 | 1 | _ | |a Hose, Dirk |b 11 |
| 700 | 1 | _ | |a Seckinger, Anja |b 12 |
| 700 | 1 | _ | |a Jauch, Anna |b 13 |
| 700 | 1 | _ | |a Raab, Marc S |b 14 |
| 700 | 1 | _ | |a Luntz, Steffen P |b 15 |
| 700 | 1 | _ | |a Besemer, Britta |b 16 |
| 700 | 1 | _ | |a Munder, Markus |b 17 |
| 700 | 1 | _ | |a Brossart, Peter |b 18 |
| 700 | 1 | _ | |a Fuhrmann, Stephan |b 19 |
| 700 | 1 | _ | |a Lindemann, Hans-Walter |b 20 |
| 700 | 1 | _ | |a Weisel, Katja |0 0000-0001-9422-6614 |b 21 |
| 700 | 1 | _ | |a Duerig, Jan |b 22 |
| 700 | 1 | _ | |a Goldschmidt, Hartmut |b 23 |
| 773 | _ | _ | |a 10.1038/s41375-021-01298-y |0 PERI:(DE-600)2008023-2 |n 10 |p 3007-3011 |t Leukemia |v 35 |y 2021 |x 1476-5551 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:168957 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)b97fc5666ea8f9db9ef499de6b2397cf |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)e15dfa1260625c69d6690a197392a994 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
| 913 | 0 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Cancer risk factors and prevention |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-01-29 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-01-29 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b LEUKEMIA : 2019 |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2021-01-29 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2021-01-29 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b LEUKEMIA : 2019 |d 2021-01-29 |
| 920 | 1 | _ | |0 I:(DE-He78)C060-20160331 |k C060 |l C060 Biostatistik |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C060-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|
guest ::